Cardiovascular Disease

In a recent comparison of guideline recommendations for initiating statin therapy in primary prevention, researchers found significant differences in the numbers who would benefit.

Your daily dose of clinical news you may have missed.

The expanded indication widens the patient population eligible for the novel siRNA therapy to include high-risk patients on maximum statin Rx who have not had a CV event.

Your daily dose of clinical news you may have missed.

In a study of over 26 000 participants, statin use was associated with reduced risk for all-cause and CV mortality compared to placebo.

Your daily dose of clinical news you may have missed.

Wellbeing is considered a measurable and modifiable community attribute that study authors show is correlated with CV outcomes.

Vitamin D supplementation may reduce the incidence of major cardiovascular events in older adults, suggests new research.

The predictive value of loneliness for cardiovascular disease in patients with diabetes was stronger than traditional lifestyle risk factors in large UK Biobank analysis.

Your daily dose of clinical news you may have missed.

SGLT-2 inhibitors were found to consistently reduce risk of CV mortality and HF events in a meta-analysis including 90 000 high-risk patients with T2D, CKD, and/or HF.

Your daily dose of clinical news you may have missed.

Your daily dose of clinical news you may have missed.

Finerenone was associated with a decrease in composite CV risk in patients with CKD, T2D, eGFR of ≥25, and moderately to severely increased albuminuria.

Increased levels of lipoprotein(a) significantly and independently predicted recurrent CHD events in adults aged 60 years and older, report study authors.

Proposed indications for the investigational factor XIa inhibitor are: stroke prevention after acute ischemic stroke or high-risk transient ischemic attack; recent acute coronary syndrome; and atrial fibrillation.

Efficacy of the daily pill met the standard now established by the once-weekly injection of 15% loss of baseline bodyweight in adults with overweight or obesity, says Novo Nordisk.

Your daily dose of clinical news you may have missed.

Results of a Mendelian randomization study showed earlier first birth, higher number of live births, and earlier menarche are all associated with increased CVD.

Your daily dose of clinical news you may have missed.

Young women who survived a myocardial infarction may have nearly double the risk of rehospitalization in the year after discharge compared to men, according to a new study.

Researchers found that reliable improvement of depressive symptoms after psychological therapy was associated with a 12% decrease in CVD risk at any given time.

Higher intake of sugar-sweetened drinks was linked to increased risk of all-cause death and CVD while healthier choices were inversely associated with both, a new study found.

Your daily dose of clinical news you may have missed.

Pregnant women with prenatal depression were found to be more likely to be diagnosed with new CVD within 2 years of delivery than those without depression.

Your daily dose of clinical news you may have missed.

Four months of meditation improved quality of life and psychological symptoms in patients with CAD, according to research presented at ESC Preventive Cardiology 2023.

Your daily dose of clinical news you may have missed.

Metabolomic signatures identified in red and processed meat are associated with an increased risk of IHD, according to new findings.

Statin therapy did not exacerbate muscle injury, pain, or fatigue in persons engaging in moderate-intensity exercise, according to a new study.